IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M
IDEXX Laboratories press release  (NASDAQ:IDXX): Q2  Non-GAAP EPS of $1.58  misses by $0.05.
Revenue of $860.55M (+4.2% Y/Y)  misses by $1.57M.

FY2022 Outlook: Revenue in the range of $3.305B to $3.385B vs. consensus of $3.41B;Â Â operating margins of 26.4% to 26.9%; EPS outlook of $7.77 - $8.05 reflects an adjustment of $0.32 at midpoint, including $0.05 of negative impact from higher projected interest rates and $0.03 of negative impact related to the strengtheningÂ U.S.Â dollar vs. consensus of $8.24.